MARKET

CHEK

CHEK

Check Cap
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.440
+0.010
+0.70%
After Hours: 1.470 +0.03 +2.08% 19:25 05/11 EDT
OPEN
1.330
PREV CLOSE
1.430
HIGH
1.499
LOW
1.320
VOLUME
1.35M
TURNOVER
--
52 WEEK HIGH
4.490
52 WEEK LOW
0.2430
MARKET CAP
101.45M
P/E (TTM)
-2.2535
1D
5D
1M
3M
1Y
5Y
The Market Slows Down As Q1 Closes Out
As we close in on the final days of March and the end of the first quarter of 2021, we’re starting to see some of the crazy action that has characterized the market in the past few months taper off as the weather warms up.
Benzinga · 03/23 15:47
Hot Penny Stocks To Watch With Big News This Week
Mar 19, 2021 (Penny Stocks via COMTEX) -- News Headlines Trigger Momentum For These Penny Stocks Are penny stocks on your watch list right now? If not, you...
Penny Stocks · 03/19 13:31
Check-Cap Reports Fourth Quarter and Full Year 2020 Financial Results
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free, screening test to detect polyps before ...
PR Newswire · 03/19 12:00
Check-Cap reports Q4 results
Check-Cap (CHEK): Q4 GAAP EPS of -$0.08 in-line.Cash and cash equivalents, restricted cash and short-term bank deposits of $18.1MPress Release
Seekingalpha · 03/19 11:06
BRIEF-Check Cap Ltd Reports Q4 2020 Financial Results
reuters.com · 03/19 11:02
Best Penny Stocks To Buy Now? These 4 Are Turning Heads
Mar 18, 2021 (Penny Stocks via COMTEX) -- Do These Biotech Penny Stocks Have Market Potential Right Now? Recently biotech penny stocks have been performing...
Penny Stocks · 03/18 13:31
DJ Check-Cap Price Target Announced at $2.00/Share by Dawson James
Dow Jones · 03/17 16:24
DJ Check-Cap Cut to Neutral From Buy by Dawson James
Dow Jones · 03/17 16:24
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CHEK. Analyze the recent business situations of Check Cap through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CHEK stock price target is 3.000 with a high estimate of 4.000 and a low estimate of 2.000.
EPS
Institutional Holdings
Institutions: 26
Institutional Holdings: 797.98K
% Owned: 1.13%
Shares Outstanding: 70.45M
TypeInstitutionsShares
Increased
0
0
New
5
588.32K
Decreased
3
57.78K
Sold Out
3
216.96K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.34%
Pharmaceuticals & Medical Research
-0.29%
Key Executives
Chairman/Director
Steven Hanley
Chief Executive Officer
Alex Ovadia
Chief Financial Officer
Mira Rosenzweig
Chief Technology Officer
Yoav Kimchy
Vice President - Operations
Joshua Belkar
Vice President
Israel Hershko
Vice President
Vardit Segal
Vice President - Research & Development
Boaz Shpigelman
Director
XiangQian Lin
Independent Director
Clara Ezed
Independent Director
Mary Jo Gorman
Independent Director
Yuval Yanai
No Data
About CHEK
Check-Cap is a Israel-based clinical-stage medical diagnostics company developing. The Company develops C-Scan, capsule-based, system ingestible imaging for colorectal cancer screening.

Webull offers kinds of Check Cap Ltd stock information, including NASDAQ:CHEK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHEK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CHEK stock methods without spending real money on the virtual paper trading platform.